학술논문
OR19 Lenalidomide: a valid therapeutic option in primary myelofibrosis (PMF)
Document Type
Abstract
Source
In Critical Reviews in Oncology / Hematology April 2012 82 Supplement 1:S15-S16
Subject
Language
ISSN
1040-8428